SKF 77434 hydrobromide

Discontinued Product

1662 has been discontinued.

View all D<sub>1</sub> and D<sub>5</sub> Receptors products.
说明: Selective D1-like partial agonist
化学名: 2,3,4,5-Tetrahydro-1-phenyl-3-(2-propenyl)-1H-3-benzazepine-7,8-diol hydrobromide
纯度: ≥99% (HPLC)
说明书
引用文献
评论
文献 (4)

生物活性 for SKF 77434 hydrobromide

SKF 77434 hydrobromide is a selective dopamine D1-like receptor partial agonist (IC50 values are 19.7 and 2425 nM for binding to D1-like and D2-like receptors respectively). Centrally active following systemic administration in vivo.

许可信息

Sold for research purposes under agreement from GlaxoSmithKline

技术数据 for SKF 77434 hydrobromide

分子量 376.29
公式 C19H21NO2.HBr
储存 Desiccate at +4°C
纯度 ≥99% (HPLC)
CAS Number 300561-58-4
PubChem ID 11957703
InChI Key JWQRAXTWDYUBFI-UHFFFAOYSA-N
Smiles Br.OC1=CC2=C(C=C1O)C(CN(CC=C)CC2)C1=CC=CC=C1

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

产品说明书 for SKF 77434 hydrobromide

分析证书/产品说明书
选择另一批次:

按标靶查看相关产品

按产品操作查看相关产品

查看全部 D1 and D5 Receptor Agonists

关键词: SKF 77434 hydrobromide, SKF 77434 hydrobromide supplier, Selective, D1-like, partial, agonists, Dopamine, Receptors, D5, dopaminergic, SKF77434, hydrobromide, GlaxoSmithKline, GSK, D1, and, 1662, Tocris Bioscience

篇 SKF 77434 hydrobromide 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 SKF 77434 hydrobromide 的引用文献。

SKF 77434 hydrobromide 的评论

目前没有该产品的评论。 Be the first to review SKF 77434 hydrobromide and earn rewards!

Have you used SKF 77434 hydrobromide?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Dopamine Receptors Scientific Review

Dopamine Receptors Scientific Review

Written by Phillip Strange and revised by Kim Neve in 2013, this review summarizes the history of the dopamine receptors and provides an overview of individual receptor subtype properties, their distribution and identifies ligands which act at each receptor subtype. Compounds available from Tocris are listed.

Addiction Poster

Addiction Poster

The key feature of drug addiction is the inability to stop using a drug despite clear evidence of harm. This poster describes the brain circuits associated with addiction, and provides an overview of the main classes of addictive drugs and the neurotransmitter systems that they target.

Depression Poster

Depression Poster

Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.

Parkinson's Disease Poster

Parkinson's Disease Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.